Fundraising Fox
/Companies
Sign in

Polku Therapeutics

5 employees on LinkedIn · 2 known investors

Find your way into Polku Therapeutics

Sign up to see every warm intro you have to Polku Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Polku Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.

BiotechDeep Tech

Founders & leadership

TTimo
TimoScientific Co-founderTimo is the scientific co-founder of Polku Therapeutics, a preclinical CNS company developing small-molecule therapies for tauopathies and related neurodegenerative diseases. He leads the NeuroCure lab at the University of Helsinki studying intracellular protein aggregation in Parkinson's and Alzheimer's disease, and has extensive experience in pharmacology and drug development spanning in vitro biochemical assays, cellular methods, and in vivo behavioral testing.
EErik
ErikScientific Co-founder
SSimon
SimonChief Executive Officer
SSebastian
SebastianChief Operating OfficerSebastian has spent a decade in life science venture roles spanning research and business development. He serves as Chief Operating Officer at Polku Therapeutics, where he oversees operations for a CNS drug discovery company developing small-molecule therapies for neurodegenerative diseases.

Investors · 2

InnovestorreportedFinland

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Polku Therapeutics do?
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.
Who founded Polku Therapeutics?
Polku Therapeutics was founded by Timo, Erik.
Who are Polku Therapeutics's investors?
Polku Therapeutics's investors include Torrey Pines Investment, Innovestor.